Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib

Triple negative breast cancer (TNBC) is characterized by lack of expression of the estrogen and progesterone receptors and HER2, which are common therapeutic targets. CDK4/6 inhibitor Palbociclib has been approved as an anti-cancer agent for breast cancer. However, identifying biomarkers that predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yuanhang, Liao, Han, Xie, Rong, Zhang, Yue, Zheng, Renjing, Chen, Jianying, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729088/
https://www.ncbi.nlm.nih.gov/pubmed/33330073
http://dx.doi.org/10.3389/fonc.2020.590813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729088/
https://www.ncbi.nlm.nih.gov/pubmed/33330073
http://dx.doi.org/10.3389/fonc.2020.590813

Ejemplares similares